Lindsay V, Allardyce R
Immunology. 1980; 40(4):571-7.
PMID: 7429543
PMC: 1458097.
Bloom E
Urol Res. 1981; 9(5):219-25.
PMID: 7303345
DOI: 10.1007/BF00256890.
Lindsay V, Allardyce R
Immunology. 1981; 43(1):125-31.
PMID: 7251046
PMC: 1555182.
Kirchner H
Klin Wochenschr. 1982; 60(1):37-47.
PMID: 6978966
DOI: 10.1007/BF01721586.
Oldham R, Gail M, Baker M, Forbes J, Heineman W, Hersh E
Cancer Immunol Immunother. 1982; 13(3):164-73.
PMID: 6762247
PMC: 11039098.
DOI: 10.1007/BF00205382.
Natural killer cells: artifact to reality: an odyssey in biology.
Oldham R
Cancer Metastasis Rev. 1983; 2(4):323-36.
PMID: 6375859
DOI: 10.1007/BF00048565.
Cytotoxic effector cells from infectious mononucleosis patients in the acute phase do not specifically kill Epstein-Barr virus genome-carrying lymphoid cell lines.
Patel P, Dorval G, Menezes J
Infect Immun. 1982; 38(1):251-9.
PMID: 6292093
PMC: 347726.
DOI: 10.1128/iai.38.1.251-259.1982.
The relationship between cytotoxicity and prognostically significant histologic changes in lymph nodes from patients with cancer of the breast.
Check I, Cobb M, Hunter R
Am J Pathol. 1980; 98(2):325-38.
PMID: 6243870
PMC: 1903411.
Natural killer cell activities of patients with breast cancer against different target cells.
Hamilton G, Reiner A, Teleky B, Roth E, Kolb R, Spona J
J Cancer Res Clin Oncol. 1988; 114(2):191-6.
PMID: 3350852
DOI: 10.1007/BF00417836.
Immunological tests in carcinoma of the prostate.
Evans C, Bowen J
Proc R Soc Med. 1977; 70(6):417-20.
PMID: 877116
PMC: 1543187.
Comparison of autochthonous and allogeneic breast-tumour cells in tests for lymphocyte immunity to human tumours.
JEEJEEBHOY H
Br J Cancer. 1977; 35(2):161-9.
PMID: 836757
PMC: 2025325.
DOI: 10.1038/bjc.1977.23.
Immunology of bronchial carcinoma.
Evans D
Thorax. 1976; 31(5):493-506.
PMID: 793085
PMC: 470466.
DOI: 10.1136/thx.31.5.493.
Cellular cytotoxicity in transitional cell carcinoma of the human urinary bladder - a summary.
Perlmann P, Troye M, Pape G, Blomgren H, Johansson B
Urol Res. 1978; 6(4):207-9.
PMID: 741533
DOI: 10.1007/BF00262619.
Relationship of cell-mediated cytotoxicity against melanoma cells to prognosis in melanoma patients.
Hershey P, Edwards A, Milton G, McCarthy W
Br J Cancer. 1978; 37(4):505-13.
PMID: 646923
PMC: 2009547.
DOI: 10.1038/bjc.1978.78.
The biology of human brain tumours.
Kumar P
Acta Neurochir (Wien). 1979; 50(1-2):7-34.
PMID: 517186
DOI: 10.1007/BF01813545.
T-cell-mediated concomitant immunity to syngeneic tumors. I. Activated macrophages as the expressors of nonspecific immunity to unrelated tumors and bacterial parasites.
NORTH R, Kirstein D
J Exp Med. 1977; 145(2):275-92.
PMID: 401860
PMC: 2180603.
DOI: 10.1084/jem.145.2.275.
The natural history of antitumour immunity in human breast cancer assayed by tube leucocyte adherence inhibition.
Lopez M, OConnor R, Macfarlane J, Thomson D
Br J Cancer. 1978; 38(6):660-73.
PMID: 369585
PMC: 2009831.
DOI: 10.1038/bjc.1978.271.
